noristerat
Small moleculeexperimental
Clinical trial activity
3 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
1
Earliest trial started Jun 1, 2014 (NCT02170038)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 1 Sponsor(trial)
Indications
Approved for
Mechanism of action
- Unspecified targetUnclear
Unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- norethindrone enanthate
- norethindrone enanthate
- norethisterone enantate
- norethisterone enantate
- norethisterone enanthate
- norethisterone heptanoate
- norigest
- noristerat
- noristerat
- noristerat
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02905890 | Phase 4 | Jan 1, 2017 | Medical Research Council, University of Liverpool, University of London |
| NCT02404038 | N/A | Jul 1, 2015 | Desmond Tutu HIV Centre, University of Cape Town |
| NCT02170038 | Phase 1 | Jun 1, 2014 | Bayer |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bayer | For profit | 1 | 1 | 1 | 2014 |
| Desmond Tutu HIV Centre | Academic/Hospital | 1 | 1 | 1 | 2015 |
| Medical Research Council | Government | 1 | 0 | 1 | 2017 |
| University of Cape Town | Academic/Hospital | 1 | 0 | 1 | 2015 |
| University of Liverpool | Academic/Hospital | 1 | 0 | 1 | 2017 |
| University of London | Academic/Hospital | 1 | 1 | 1 | 2017 |
6 organizations
Page 1 / 1